In his discussion “Cell-based Precision Medicine Approaches to Pulmonary Fibrosis – Insight from the IPF Cell Atlas,” Naftali Kaminski, MD of the Yale School of Medicine shares his insights from…
Read More »
Pulmonary Fibrosis Foundation
Aryeh Fischer, MD explains the importance of assessing for autoimmune disease in interstitial lung disease patients. Learn more about autoimmune diseases, interstitial lung diseases, and life with pulmonary fibrosis at…
Read More »
The purpose of a clinical trial is to study the effectiveness of a drug or device. In order for it to be available on the market, it must complete four…
Read More »
Jonathan Kropski, MD of Vanderbilt University shares his key message that genetic factors confer similar disease risk across a spectrum of ILD phenotypes. Social media platforms – Twitter – @PFFORG…
Read More »
The Pulmonary Fibrosis Foundation (PFF) is closely monitoring the impact of the COVID-19 coronavirus outbreak. People with chronic illnesses, such as pulmonary fibrosis (PF), may be at higher risk for…
Read More »
Pulmonary rehabilitation and supplemental oxygen have been shown to help improve the quality of life for people living with pulmonary fibrosis (PF). Anne E. Holland, PhD, presenting at the PFF…
Read More »
Oncologist Mary Armanios, MD explains the correlations between telomerase and telomere gene mutations and pulmonary fibrosis. Learn more about the potential causes of pulmonary fibrosis at http://www.pulmonaryfibrosis.org/life-with-pf/about-pf. This activity is…
Read More »
Discussing the prognosis and impact of pulmonary fibrosis (PF) can be difficult for both patients and physicians. Sonye K. Danoff, MD, PhD, presenting at the PFF Summit 2015: From Bench…
Read More »
Lida Hariri, MD discusses using new imaging technology as a potential method for diagnosis in IPF and other ILDs. Learn more about diagnostics and test for pulmonary fibrosis at http://www.pulmonaryfibrosis.org/life-with-pf/about-pf.…
Read More »
Harold R. Collard, MD of UC San Francisco shares past research regarding gastroesophageal reflux (GERD) and idiopathic pulmonary fibrosis, and discusses where we should go from here. Social media platforms…
Read More »
